Evidence map›Paper›PMID 32733444›Full record

ArticleFrontiers in immunology2020

Ji Zongfei, Chen Rongyi, Cui Xiaomeng, Ma Lili, Ma Lingying, Kong Xiufang, Dai Xiaomin, Zhang Zhuojun, Chen Huiyong, Sun Ying and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Interleukin-6 is critical in the development of pulmonary vascular disease inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Association between interleukin-6-174G/C gene polymorphism and asthma severity: exploring the role of total serum IgE, blood eosinophils, and FeNO as markers of type 2 inflammation.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ji ZongfeiDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Chen RongyiDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Cui XiaomengDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ma LiliDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ma LingyingDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Kong XiufangDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Dai XiaominDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang ZhuojunDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Chen HuiyongDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Sun YingDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jiang LindiDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Fudan University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Signal TransductionBiomarkersCells, CulturedCytokinesDisease SusceptibilityFemaleFibroblastsFluorescent Antibody TechniqueHumansImmunoglobulin G4-Related DiseaseImmunohistochemistryInterleukin-6Janus Kinase 1Janus Kinase 2Lymphocyte ActivationMaleBiomarkersCytokinesInterleukin-6JAK1 protein, humanJAK2 protein, humanJanus Kinase 1Janus Kinase 2Oncogene Protein v-aktProto-Oncogene Proteins c-aktReceptors, Interleukin-6STAT3 protein, humanSTAT3 Transcription FactorB cellB cell activating factorfibroblastsgerminal centerIgG4-related diseaseinterleukin-6T follicular helper cell

Identifiers

PMID32733444
PMCPMC7360847
OpenAlexW3031817190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.